Late Gadolinium Enhancement (LGE) has been shown to be a poor prognostic indicator in LV failure. However, it has not been studied in predicting adverse prognosis in Pulmonary Hypertension (PH). Herein we show that LGE enhancement predicts major adverse clinical events (MACE) in PH patients.
β¦ LIBER β¦
LGE in pulmonary hypertension predicts clinical events
β Scribed by Siva Soma; Srinivas Murali; Raymond Benza; June A Yamrozik; Ronald B Williams; Mark Doyle; Diane Vido; Robert WW Biederman; Vikas Rathi
- Publisher
- BioMed Central
- Year
- 2011
- Tongue
- English
- Weight
- 144 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1097-6647
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Late gadolinium enhancement in pulmonary
β
Siva Kumar Soma; Vishal Goyal; Vikas K Rathi; Mark Doyle; Srinivas Murali; Diane
π
Article
π
2012
π
BioMed Central
π
English
β 86 KB
Clinical practice: pulmonary hypertensio
β
Daniel De Wolf
π
Article
π
2009
π
Springer
π
English
β 213 KB
Clinical aspects of pulmonary hypertensi
β
Son-Mi Chung; Chang-Keun Lee; Eun Young Lee; Bin Yoo; Sang-Do Lee; Hee-Bom Moon
π
Article
π
2006
π
Springer
π
English
β 131 KB
Clinical predictors of pulmonary hyperte
β
Nektarios D. Pilatis; Larry E. Jacobs; Pairoj Rerkpattanapipat; Morris N. Kotler
π
Article
π
2000
π
John Wiley and Sons
π
English
β 68 KB
Clinical prediction of portopulmonary hypertension (PPHTN) is critical in the preoperative evaluation of candidates for orthotopic liver transplantation (OLT) because of its association with significant morbidity and mortality. To determine the clinical, laboratory, and echocardiographic predictors
Clinical response to sildenafil in pulmo
β
C. J. C. Fernandes; C. Jardim; L. A. S. Carvalho; A. Q. Farias; M. Terra Filho;
π
Article
π
2005
π
Springer
π
English
β 46 KB
Prediction of pulmonary hypertension rel
β
Christophe Meune; JΓ©rΓ΄me Avouac; Paolo AirΓ²; Lorenzo Beretta; Philippe DieudΓ©; K
π
Article
π
2011
π
John Wiley and Sons
π
English
β 120 KB
π 1 views